Subscribe
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
SABCS 2023 - HER2+ MBC
ASCO 2023 - Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quizzes
Press Releases
AVBCC
Association for Value-Based Cancer Care
VBCM
Value-Based Care in Myeloma
Chemotherapy
Chemotherapy Can Be Spared in Many Patients with Early Breast Cancer: Devil Is in the Details
By
Phoebe Starr
Breast Cancer
,
Chemotherapy
,
Personalized Medicine
August 2018, Vol 9, No 2 | Payers’ Perspectives In Oncology: ASCO
Read Article
The Evolution of Chemotherapy-Induced Nausea and Vomiting Management: Challenges and Opportunities
By
John A. Welz, MPH
Chemotherapy
,
CINV Management
,
Personalized Medicine
June 2017, Vol 8, No 3, Supplement 2: The Evolution of Chemotherapy-Induced Nausea and Vomiting Management: Challenges and Opportunities
Read Article
Chemotherapy Use in Breast Cancer Declines with Gene-Based Assay
By
Charles Bankhead
Chemotherapy
,
Value in Oncology
,
Personalized Medicine
June 2016, Vol 7, No 5
Women with clinicopathologic high-risk breast cancer had nearly a 50% reduction in prescription chemotherapy, with no increased risk for metastatic recurrence when a cancer gene-based assay was used to guide treatment decision-making, according to new data presented at the 2016 American Association for Cancer Research meeting.
Read Article
Chemotherapy Safe During Pregnancy in Second and Third Trimesters
By
Phoebe Starr
Chemotherapy
,
Pregnancy & Cancer
,
Personalized Medicine
November 2015, Vol 6, No 10
Vienna, Austria—Results from a new study provide reassurance to women who have cancer while pregnant that they can safely receive treatment during the second or third trimester with chemotherapy or radiation without compromising their unborn child. The study showed that children born to mothers who receive chemotherapy or radiation during pregnancy had no impairment in general health, cognition, or cardiac function compared with children born to healthy mothers, said lead investigator Frédéric Amant, MD, PhD, Department of Gynecologic Oncology, University Hospitals Leuven, Belgium.
Read Article
Risk of Leukemia after Chemotherapy Small, but Real
By
Audrey Andrews
Chemotherapy
,
Personalized Medicine
March 2013, Highlights
Fewer than 0.5% of patients with breast cancer develop leukemia associated with chemotherapy, but this is 60% higher than the proportion documented in a previous analysis, according to a report based on the National Comprehensive Cancer Network (NCCN) database.
Read Article
Adjuvant Chemotherapy Reduces Local and Regional Tumor Recurrence, Especially for Patients with ER-Negative Breast Cancer
By
Susan Reckling
Chemotherapy
,
Personalized Medicine
March 2013, Highlights
Adjuvant chemotherapy should be recommended for patients with completely resected, isolated local or regional recurrence (ILRR) of breast cancer, and the argument is strongest for women with estrogen receptor (ER)-positive tumor recurrences, according to the results of the international Chemotherapy as Adjuvant for Locally Recurrent Breast Cancer (CALOR) trial.
Read Article
Dose-Dense Chemotherapy in Breast Cancer
By
Audrey Andrews
Chemotherapy
,
Personalized Medicine
March 2013, Highlights
Two studies presented in San Antonio reached conflicting conclusions regarding the value of dose-dense chemotherapy in patients with early breast cancer.
Read Article
“Chemo Brain” May Be Present Before Chemotherapy
By
Caroline Helwick
Chemotherapy
,
Personalized Medicine
March 2013, Highlights
Chemotherapy may not necessarily be the reason that patients with breast cancer often complain of “fuzzy thinking” and difficulty solving problems, according to research showing that cognitive changes are present in some patients at baseline, and may be related to fatigue and anxiety.
Read Article
Gabriel N. Hortobagyi, MD, Delivers the William I. McGuire Memorial Lecture
By
Caroline Helwick
Chemotherapy
,
Personalized Medicine
March 2013, Highlights
The honor of delivering the William I. McGuire Memorial Lecture at this year’s meeting went to Gabriel N. Hortobagyi, MD, FACP, Professor of Breast Medical Oncology and Nellie B. Connally Chair in Breast Cancer at the University of Texas M.D. Anderson Cancer Center, Houston.
Read Article
Chemotherapy Administration Sequencing Chart
Chemotherapy
,
Personalized Medicine
March 2012, Vol 3, No 2
We conducted a literature search for data supporting same-day chemotherapy administration sequences. This was achieved by searching PubMed using keywords and any combination of the drug name with "administration," "sequencing," or "interactions."
Read Article
Page 1 of 2
1
2
View the Latest Issue of VBCC
Read Issue
Top Trending Articles
1.
Navigating the Complex Landscape of Oral Cancer Medication
2.
Luspatercept Yields Improved Transfusion Independence Compared With Epoetin Alfa in Patients With Lower-Risk MDS
Phoebe Starr
3.
New NCCN Guidelines for CLL/SLL Include Second-Generation BTK Inhibitors
Wayne Kuznar
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
SABCS 2023 - HER2+ MBC
ASCO 2023 - Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quizzes
Press Releases
AVBCC
Association for Value-Based Cancer Care
VBCM
Value-Based Care in Myeloma